Doro AB

  • ISIN: SE0000215493
  • Land: .

Nachricht vom 21.03.2012 | 17:00

Bulletin from Doro AB’s Annual General Meeting 2012


Doro AB 

21.03.2012 17:00

Lund, Sweden, 2012-03-21 17:00 CET (GLOBE NEWSWIRE) -- At the Annual General Meeting of Doro AB (publ), held on 21 March 2012, it was resolved, inter alia: * to adopt the income statement and balance sheet, and the consolidated income statement and the consolidated balance sheet; * to distribute a dividend of SEK 1 per share for the financial year 2011; * to discharge from liability the members of the board of directors and the CEO for the financial year 2011; * to re-elect Bo Kastensson, Karin Moberg, Jonas Mårtensson, Jérôme Arnaud and Charlotta Falvin as members of the board of directors for the period up to and including the next annual general meeting; * to re-elect Bo Kastensson as the chairman of the board of directors; * remuneration to the board as follows: the chairman receives SEK 350,000 and other members not employed by the company receive SEK 150,000 each; * to adopt principles for the appointment of the nomination committee; * to authorize the board, for the period until the next annual general meeting, to resolve, on one or several occasions, to issue not more than 1,930,000 shares without preferential rights for the shareholders. Such new issue resolution shall include a provision that new shares shall be paid in kind; and * to adopt remuneration guidelines with the principal effect that salaries and other terms of remuneration for the group management shall be on market terms. For more information, please contact: President and CEO Jérôme Arnaud, +46 (0)46 280 50 05, or Vice President and CFO Annette Borén, +46 (0)706 30 00 09. This is information that Doro AB (publ) is required to publish in accordance with the Swedish Securities Markets Act and/or the Swedish Financial Trading Act. This information was submitted for publication on March 21, 2012 at 5 p.m CET. News Source: NASDAQ OMX 21.03.2012 Dissemination of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de
Language: English Company: Doro AB Sweden Phone: Fax: E-mail: Internet: ISIN: SE0000215493 WKN: End of Announcement DGAP News-Service

GBC im Fokus

23. MKK – Münchner Kapitalmarkt Konferenz

Für: Institutionelle Investoren & Presse

Wann: 26. & 27. April 2017, 9 - 17 Uhr

Wo: The Charles Hotel - Rocco Forte Hotels, München

GBC im Fokus

Neovacs S.A.: Kursziel auf 3,30 € angehoben

In den letzten Monaten hatte die Neovacs S.A. einen positiven Newsflow. Im Vordergrund steht die Vertriebspartnerschaft für den chinesischen Markt, wodurch sich bis nach dem ersten Vermarktungsjahr Gesamterträge von bis zu 65 Mio. € ergeben können. Zudem verläuft der klinische Zulassungsprozess des IFNα-Kinoid zur Behandlung von SLE (Systemischer Lupus) und Dermatomyositis planmäßig. Wir haben in unsere Bewertung aktualisiert und ein Kursziel von 3,30 € je Aktie (bisher: 2,90 €) ermittelt. Das Rating lautet weiter KAUFEN.

News im Fokus

Bayerische Motoren Werke Aktiengesellschaft: Vorsteuerergebnis und Umsatz der BMW Group im ersten Quartal 2017 über Markterwartungen

20. April 2017, 12:11

Aktueller Webcast

Scout24 AG

Q1 Results 2017

10. Mai 2017

Aktuelle Research-Studie

Vita 34 AG

Original-Research: Vita 34 AG (von Montega AG): Kaufen

21. April 2017